Molecular Mechanisms of Tumor Progression and Plasticity in Bladder Cancer Endeavor Award (2020-Present) Cory Abate-Shen, PhD, and Michael Shen, PhD, Columbia University - Principal Investigators Read More
Understand and Eliminate Metastatic Cancers Endeavor Award (2020-Present) Andrei Goga, MD, PhD; Eric Collisson, MD; Jay Debnath, MD, PhD; Sarah Knox, PhD; Jeroen Roose, PhD; and Valerie Weaver, PhD, University of California, San Francisco - Principal Investigators Read More
Host Response to Cancer Endeavor Award (2020-Present) Tobias Janowitz, MD, PhD and Semir Beyaz, PhD, Cold Spring Harbor Laboratory - Principal Investigators Read More
Impact of Aging on Lung Tumorigenesis 2021 Emerging Leader Award Tuomas Tammela, MD, PhD, Memorial Sloan Kettering Cancer Center Read More
Cellular and Molecular Drivers of Obesity-Associated Breast Cancer 2021 Emerging Leader Award Paul Cohen, MD, PhD, Rockefeller University Read More
Targeting Oncogenic Proteoforms Using Tyrosine-Reactive Chemistry 2021 Emerging Leader Award Ku-Lung (Ken) Hsu, PhD, University of Virginia Read More
Deciphering Organellar Oxidative Metabolism in Kras-Driven Cancers 2021 Emerging Leader Award Kıvanç Birsoy, PhD, Rockefeller University Read More
In vivo Forward Genetic Screens to Identify Immunotherapy Resistance Mechanisms and Synergistic Treatment Combinations for Cancer 2021 Emerging Leader Award Hao Zhu, MD, Children’s Medical Center Research Institute at UT Southwestern Read More
Identifying and Targeting 3D Enhancer Hubs that Maintain Cancer Stem Cell Programs 2021 Emerging Leader Award Effie Apostolou, PhD, Weill Cornell Medicine Read More
Causes and Consequences of Rapid Cancer Cell Adaptation to MAPK Pathway Inhibitors 2021 Emerging Leader Award Sabrina Spencer, PhD, University of Colorado Boulder Read More
Decoding the Regulatory Network of Tumor Progression in Childhood Ependymoma ASPIRE Award (2021-Present) Pablo Gonzalez Cámara, PhD, University of Pennsylvania Read More
Engineering TILs to Utilize Kynurenine as an Essential Nutrient for Survival in the Tumor Microenvironment In Partnership with Emerson Collective (2021-Present) David Hockenbery, MD, Fred Hutchinson Cancer Research Center Read More
Evolution of Megakaryocyte Abnormalities in the Progression of Primary Myelofibrosis The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present) Johanna Melo-Cardenas, PhD, St. Jude Children’s Research Hospital Read More
